BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38236307)

  • 1. Differential DNA methylation and CTCF binding between the ESR1 promoter a of MCF-7 and MDA-MB-231 breast cancer cells.
    Montes-de-Oca-Fuentes EV; Jácome-López K; Zarco-Mendoza A; Guerrero G; Ventura-Gallegos JL; Juárez-Méndez S; Cabrera-Quintero AJ; Recillas-Targa F; Zentella-Dehesa A
    Mol Biol Rep; 2024 Jan; 51(1):148. PubMed ID: 38236307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-Specific Expression of Estrogen Receptor 1 Is Regulated by DNA Methylation in a T-DMR.
    Maekawa R; Sato S; Okada M; Lee L; Tamura I; Jozaki K; Kajimura T; Asada H; Yamagata Y; Tamura H; Yamamoto S; Sugino N
    Mol Endocrinol; 2016 Mar; 30(3):335-47. PubMed ID: 26683811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 Binds to estrogen receptor 1 promoter in human breast cancer cells.
    Rasti M; Arabsolghar R; Khatooni Z; Mostafavi-Pour Z
    Pathol Oncol Res; 2012 Apr; 18(2):169-75. PubMed ID: 21655924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant p53 binds to estrogen receptor negative promoter via DNMT1 and HDAC1 in MDA-MB-468 breast cancer cells.
    Arabsolghar R; Azimi T; Rasti M
    Mol Biol Rep; 2013 Mar; 40(3):2617-25. PubMed ID: 23242655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues.
    Shenker NS; Flower KJ; Wilhelm-Benartzi CS; Dai W; Bell E; Gore E; El Bahrawy M; Weaver G; Brown R; Flanagan JM
    BMC Cancer; 2015 May; 15():337. PubMed ID: 25927974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivative of Stevioside; CPUK02; Restores ESR1 Gene Methylation in MDA-MB 231.
    Khazayel S; Mokarram P; Mohammadi Z; Ramezani F; Dayong Z
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2117-2123. PubMed ID: 30139210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion.
    Guo Y; Pakneshan P; Gladu J; Slack A; Szyf M; Rabbani SA
    J Biol Chem; 2002 Nov; 277(44):41571-9. PubMed ID: 12198113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients.
    Martínez-Galán J; Torres-Torres B; Núñez MI; López-Peñalver J; Del Moral R; Ruiz De Almodóvar JM; Menjón S; Concha A; Chamorro C; Ríos S; Delgado JR
    BMC Cancer; 2014 Feb; 14():59. PubMed ID: 24495356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer.
    Ramos EA; Camargo AA; Braun K; Slowik R; Cavalli IJ; Ribeiro EM; Pedrosa Fde O; de Souza EM; Costa FF; Klassen G
    BMC Cancer; 2010 Jan; 10():23. PubMed ID: 20109227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESR1-promoter-methylation status in primary breast cancer and its corresponding metastases.
    Kirn V; Strake L; Thangarajah F; Richters L; Eischeid H; Koitzsch U; Odenthal M; Fries J
    Clin Exp Metastasis; 2018 Oct; 35(7):707-712. PubMed ID: 30173322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer: A systematic meta-analysis under the guideline of PRISMA.
    Sheng X; Guo Y; Lu Y
    Medicine (Baltimore); 2017 Jul; 96(28):e7476. PubMed ID: 28700487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic changes of CXCR4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer.
    Ramos EA; Grochoski M; Braun-Prado K; Seniski GG; Cavalli IJ; Ribeiro EM; Camargo AA; Costa FF; Klassen G
    PLoS One; 2011; 6(12):e29461. PubMed ID: 22220212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Changes of the ESR1 Gene in Breast Tissue of Healthy Women: A Missing Link with Breast Cancer Risk Factors?
    Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Bastami M; Tavakkoly-Bazzaz J
    Genet Test Mol Biomarkers; 2017 Aug; 21(8):464-470. PubMed ID: 28708432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTCF loss mediates unique DNA hypermethylation landscapes in human cancers.
    Damaschke NA; Gawdzik J; Avilla M; Yang B; Svaren J; Roopra A; Luo JH; Yu YP; Keles S; Jarrard DF
    Clin Epigenetics; 2020 Jun; 12(1):80. PubMed ID: 32503656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mechanism for CTCF in the epigenetic regulation of Bax in breast cancer cells.
    Méndez-Catalá CF; Gretton S; Vostrov A; Pugacheva E; Farrar D; Ito Y; Docquier F; Kita GX; Murrell A; Lobanenkov V; Klenova E
    Neoplasia; 2013 Aug; 15(8):898-912. PubMed ID: 23908591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of estrogen receptor α expression in breast cancer cells by metastasis-associated protein 1.
    Kang HJ; Lee MH; Kang HL; Kim SH; Ahn JR; Na H; Na TY; Kim YN; Seong JK; Lee MO
    Cancer Res; 2014 Mar; 74(5):1484-94. PubMed ID: 24413532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyper-methylation of the upstream CpG island shore is a likely mechanism of GPER1 silencing in breast cancer cells.
    Manjegowda MC; Gupta PS; Limaye AM
    Gene; 2017 May; 614():65-73. PubMed ID: 28286086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESR1 and PGR gene promoter methylation and correlations with estrogen and progesterone receptors in ductal and lobular breast cancer.
    Medina-Jaime AD; Reyes-Vargas F; Martinez-Gaytan V; Zambrano-Galvan G; Portillo-Delcampo E; Burciaga-Nava JA; Reyes-Romero M; Sifuentes-Alvarez A
    Asian Pac J Cancer Prev; 2014; 15(7):3041-4. PubMed ID: 24815444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer.
    Stone A; Zotenko E; Locke WJ; Korbie D; Millar EK; Pidsley R; Stirzaker C; Graham P; Trau M; Musgrove EA; Nicholson RI; Gee JM; Clark SJ
    Nat Commun; 2015 Jul; 6():7758. PubMed ID: 26169690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the CpG methylation status of ER alpha gene in estrogen receptor alpha-negative breast cancer cell lines and the role of hydralazine demethylation].
    Tang B; Jiang J
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):283-7. PubMed ID: 16181550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.